ArticleFrontiers in systems biology2026
Latent multimorbidity classes and antithrombotic medication distributions among patients hospitalized for bleeding after dental surgery: a retrospective study.
Article in Frontiers in systems biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: To characterize patients hospitalized for postoperative intraoral bleeding after dental surgery and to describe latent multimorbidity classes and their observed antithrombotic medication distributions. Materials and Methods: This single-center retrospective study included 700 patients hospitalized between 2011 and 2021. Demographic characteristics, clinical measurements, comorbidities, and antithrombotic medication categories were extracted from medical records. Latent class analysis was performed in 458 patients with at least two documented comorbidities using 11 binary indicators. Models containing one to six classes were compared using information criteria, entropy, the bootstrap likelihood ratio test, class size, and clinical interpretability. Stability of the selected solution was assessed using 100 bootstrap resamples. Results: The median age was 74 years, 460 patients (65.7%) were male, and 581 (83.0%) were receiving at least one antithrombotic medication. A five-class solution was selected. Class 1 (n = 26, 5.7%) was characterized by deep venous thrombosis, hypertension, and cardiac disease; Class 2 (n = 97, 21.2%) by heart valve replacement and cardiac disease; Class 3 (n = 55, 12.0%) by stroke, cardiac disease, and hypertension; Class 4 (n = 151, 33.0%) by hypertension and cardiac disease; and Class 5 (n = 129, 28.2%) by a broader multisystem profile involving cardiac disease, hypertension, diabetes, renal disease, and gastrointestinal disease. Vitamin K antagonist (VKA) use was most frequent in Classes 1 and 2, whereas direct oral anticoagulant (DOAC) use was most frequent in Class 4. Bootstrap analysis indicated moderate overall stability. Conclusion: The study describes clinically relevant heterogeneity among hospitalized bleeding cases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.